Sphera Funds Management Ltd. Ptc Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 118,345 shares of PTCT stock, worth $5.43 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
118,345
Previous 94,318
25.47%
Holding current value
$5.43 Million
Previous $2.88 Million
52.22%
% of portfolio
0.81%
Previous 0.42%
Shares
12 transactions
Others Institutions Holding PTCT
# of Institutions
225Shares Held
78MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$419 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$362 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$357 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$339 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$332 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.28B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...